Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Asian Pac J Trop Med ; 4(10): 786-90, 2011 Oct.
Article in English | MEDLINE | ID: mdl-22014733

ABSTRACT

OBJECTIVE: To investigate experimentally the possible antitumor effect of methanol extract (ME) of Calotropis gigantea L. (C. gigantean) root bark and its petroleum ether (PEF) and chloroform (CF) soluble fractions against Ehrlich ascites carcinoma (EAC) in Swiss albino mice. METHODS: The effects of ME (10 and 20 mg/kg), PEF (40 and 80 mg/kg) and CF (20 and 40 mg/kg) on the growth of EAC and life span of EAC bearing mice were studied. Hematological profile and biochemical parameters (SALP, SGPT and SGOT) were also estimated. RESULTS: Results of in vivo study showed a significant decrease in viable tumor cell count and a significant increase of life span in the ME and CF treated group compared to untreated one. The life span of ME and CF treated animals was significantly (P<0.05) increased by 43.90% (20 mg ME/kg) and 57.07% (40 mg CF/kg). ME and CF brought back the hematological parameter more or less normal level. ME and CF also restored the altered levels of serum alkaline phosphatase (SALP) and serum glutamate oxaloacetate transaminase (SGOT). CONCLUSIONS: Methanol extract (ME) of C. gigantea root bark and its chloroform soluble fraction (CF) possesses significant antitumor activity.


Subject(s)
Calotropis/chemistry , Carcinoma, Ehrlich Tumor/drug therapy , Phytotherapy , Plant Extracts/pharmacology , Plant Roots/chemistry , Alkanes/administration & dosage , Alkanes/pharmacology , Animals , Biomarkers, Tumor/blood , Carcinoma, Ehrlich Tumor/blood , Chloroform/administration & dosage , Chloroform/pharmacology , Mice , Plant Extracts/administration & dosage
2.
Asian Pac J Trop Biomed ; 1(6): 448-51, 2011 Dec.
Article in English | MEDLINE | ID: mdl-23569811

ABSTRACT

OBJECTIVE: To evaluate the antitumor activity of Manilkara zapota (M. zapota) L. stem bark against Ehrlich ascites carcinoma (EAC) in Swiss albino mice. METHODS: The in vivo antitumour activity of the ethyl acetate extract of stem bark of M. zapota L. (EASM) was evaluated at 50, 100 and 200 mg/kg bw against EAC using mean survival time. After administration of the extract of M. zapota, viable EAC cell count and body weight in the EAC tumour hosts were observed. The animal was also observed for improvement in the haematological parameters (e.g., heamoglobin content, red and white blood cells count and differential cell count) after EASM treatment. RESULTS: Intraperitoneal administration of EASM reduced viable EAC cells, increased the survival time, and restored altered haematological parameters. Significant efficacy was observed for EASM at 100 mg/kg dose (P<0.05). CONCLUSIONS: It can be concluded that the ethyl acetate extract of stem bark of M. zapota L. possesses significant antitumour activity.


Subject(s)
Antineoplastic Agents/therapeutic use , Carcinoma, Ehrlich Tumor/drug therapy , Manilkara/chemistry , Plant Extracts/therapeutic use , Animals , Antineoplastic Agents/isolation & purification , Body Weight , Cell Survival/drug effects , Disease Models, Animal , Injections, Intraperitoneal , Male , Mice , Plant Bark/chemistry , Plant Extracts/isolation & purification , Survival Analysis , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...